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clarifi ed. Th erefore, it is important to con-
sider tuberculosis in any member of an 
at-risk community with renal dysfunction 
in whom no specifi c renal diagnosis has 
been made. 
 Unfortunately, the spectrum of disease 
processes that produce a picture of inter-
stitial nephritis is ill understood, let alone 
the mechanisms outlined here in cases 
associated directly or indirectly with 
tuberculous infection. Interstitial nephri-
tis has never had the glamour of glomeru-
lonephritis and has received much less 
attention. Th ere is now a case for a radical 
reevaluation of this group of interstitial 
diseases to move them to a level of under-
standing comparable to that of glomerular 
disease and to pinpoint the complex 
etiological, genetic, and immunological 
processes that cause them. 
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 Segmental glomerulosclerosis is charac-
terized by a segmental increase in glomer-
ular matrix with obliteration of capillary 
lumens and is a common morphological 
feature in biopsies, either as the only man-
ifestation of glomerular injury or in com-
bination with other pathology. Because 
the lesions usually affect only some 
glomeruli, this is termed focal segmental 
glomerulosclerosis (FSGS). Th ere are at 
least two mechanisms by which such 
lesions develop. Th ey may form secondary 
to an initial lesion of glomerular infl am-
mation or necrosis as, for example, occurs 
in ANCA-associated glomerulonephritis, 
in which it is common to see biopsies with 
both active necrotizing lesions and seg-
mental glomerulosclerosis. Or these 
lesions may form as a consequence of 
podocyte injury, as has been elegantly 
shown in the work of Kriz and co-workers 
by detailed analysis of animal models. 1 
Th ey have demonstrated that loss of podo-
cytes with denuding of the glomerular 
basement membrane is followed by an 
adhesion to Bowman ’ s capsule and then 
the formation of a sclerotic lesion. In some 
cases of primary FSGS there is evidence 
for a circulating toxin that damages the 
podocyte, whereas in other settings the 
podocyte damage may be secondary to 
hemodynamic changes as a response to 
loss of functioning nephrons. 
 Segmental sclerotic lesions are com-
monly seen in glomeruli in immunoglob-
ulin A (IgA) nephro pathy. In the recently 
published Oxford classifi cation of IgA 
nephropathy, 2 the presence of segmental 
sclerosis (S) was one of the four features 
that were found to predict an adverse 
outcome. The others were mesangial 
hypercellularity (M), endocapillary 
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 Segmental sclerosis is frequently seen in IgA nephropathy and is an 
adverse prognostic indicator in the Oxford classification. Hill and 
colleagues have studied patients with IgA nephropathy and show that 
the segmental sclerotic lesions have features that suggest they are due 
to primary podocyte injury. They confirm the validity of the Oxford 
classification in predicting outcome and also show that categorizing the 
type of FSGS is of prognostic significance, with collapsing and cellular 
forms having the worst outcome. 
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hypercellularity (E), and tubulointersti-
tial fi brosis (T). Th e classi fi cation there-
fore gives a score for each of these 
variables, with M, E, and S having a value 
of 0 or 1 depending on whether the fea-
ture was present or absent, and T being 
given a score of 0, 1, or 2 corresponding 
to 0 – 25 % , 26 – 50 % , and   >  50 % tubu-
lointerstitial fi brosis. Th is international 
collaborative study showed that each of 
these variables had independent value in 
predicting clinical outcome. It is worth 
noting that in scoring segmental sclerosis 
the authors counted adhesions together 
with segmental sclerosis, since this 
improved interobserver agreement. 
 I think that many renal pathologists 
have assumed that the sclerotic lesions 
seen in IgA nephropathy form mainly as 
a consequence of healing of infl ammatory 
lesions and thus act as a measure of previ-
ous infl ammation. However, two related 
papers by Gary S. Hill and his co-workers 
in Paris in this issue of  Kidney Interna-
tional 3,4 provide evidence that in many 
cases the sclerotic lesions in IgA neph-
ropathy are more like those in primary 
FSGS. Th ey have also examined the valid-
ity of the Oxford classifi cation in their 
cohort of patients. 
 Th ey studied 128 biopsies, which rep-
resented all their adult patients with IgA 
nephropathy and adequate biopsies over 
a 6-year period. Th is was a homogeneous 
group none of whom was treated with 
immunosuppressive agents aft er biopsy. 
As they report in the first paper, 3 the 
authors carried out a detailed analysis of 
the histological and immunohistochemi-
cal features of focal and segmental scle-
rosis in the biopsies. Firstly, they showed 
that it was very common to find foci 
where the glomerular tuft  was adherent 
to Bowman ’ s capsule without any infl am-
mation in the underlying glomerular tuft . 
Th is was present in 41 % of their cases of 
IgA nephropathy compared with only 8 % 
of cases of lupus glomerulonephritis that 
they examined. In primary FSGS the fi g-
ure was 69 % . Th us, in terms of adhesions, 
IgA nephropathy behaves more like pri-
mary FSGS than like an immune complex 
glomerulonephritis. Secondly, the authors 
carried out a detailed study in a small 
subset of their cases looking at immuno-
histochemical markers of podocytes and 
parietal epithelial cells. In summary, they 
showed that at the site of capsular adhe-
sions there was loss of podocyte markers 
such as GLEPP-1 and nephrin. In larger 
sclerotic lesions there was not only loss of 
podocyte markers but also accumulation 
of cells overlying the lesions that stained 
with markers of parietal epithelial cells 
such as cytokeratins or PAX2. These 
detailed studies suggest that, at least in 
some instances, the segmental sclerotic 
lesions in IgA nephropathy may represent 
a primary podocyte injury progressing to 
sclerosis rather than occurring secondary 
to post-inflammatory scarring. This 
would fi t with  in vitro evidence suggest-
ing that when mesangial cells are stimu-
lated by IgA from patients with IgA 
nephropathy they release mediators that 
lead to podocyte injury, 5,6 and also with 
the fact that excretion of podocytes in the 
urine refl ects disease progression. 7 
 So far I have discussed segmental  sclerosis 
in two categories — post- infl ammatory and 
secondary to podocyte injury — but morpho-
logically it is possible to recognize several 
patterns of segmental sclerosis, as was 
described by the patho logists who devised 
what is commonly referred to as the 
Columbia classifi cation of FSGS. 8 Th ey 
recognized four distinct morphological 
variants — collapsing, tip, cellular, and 
perihilar — and categorized the remaining 
forms as  ‘ not otherwise specifi ed. ’ In the 
second paper, 4 Hill and colleagues have 
categorized the types of segmental 
s clerosis seen in their biopsies according 
to a modifi ed version of this classifi cation. 
Th ey looked at the clinical outcomes in 
their 128 patients and asked how progres-
sion of disease relates to the pathological 
features identifi ed in the Oxford classifi ca-
tion and also how the diff erent types of 
FSGS are related to outcome. With regard 
to the Oxford classifi cation, they show that 
in univariate analysis all of the four 
 features — mesangial hypercellularity (M), 
endocapillary hypercellularity (E), seg-
mental sclerosis (S), and tubulointerstitial 
fibrosis (T) — were significantly more 
likely to be present in patients with a bad 
outcome, defi ned as doubling of serum 
creatinine or need for dialysis. In multi-
variate analysis mesangial hypercellular-
ity was associated with bad outcome and 
tubulointerstitial scarring with rate of 
decline of renal function, with endo-
capillary hypercellularity almost reaching 
statistical signifi cance. Th e authors con-
clude that their study confi rms the valid-
ity of the Oxford criteria in a cohort with 
somewhat more advanced disease. 
 When they looked at the diff erent types 
of segmental sclerosis, they found that 
they were able to classify almost all their 
cases using slightly modifi ed Columbia 
criteria. One of the questions they had to 
deal with was to try to distinguish those 
lesions that are just post-infl ammatory 
from those that are secondary to podocyte 
injury, and this was why they modifi ed the 
criteria. In order to avoid including post-
infl ammatory scarring, they required that, 
at a minimum, the sclerotic lesions should 
also have either overlying epithelial 
 proliferation or hyalinosis lesions. Th eir 
results show that they were able to success-
fully classify most of the biopsies with seg-
mental sclerosis using this system. Th ey 
show that patients with FSGS have a much 
worse renal survival than patients without 
FSGS, and also that the diff erent types of 
FSGS they can identify have different 
eff ects on outcome, with the cellular and 
collapsing forms having particularly bad 
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 Figure 1  |  Possible pathways by which segmental glomerulosclerosis develops in 
immunoglobulin A (IgA) nephropathy. 
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that they draw attention to the diffi  culties 
in deciding whether hypercellularity in 
Bowman ’ s space represents a true crescent 
or proliferation of parietal epithelial 
cells — this may confound attempts to 
assess the prognostic signifi cance of ext-
racapillary proliferation. 
 Th ere are some points that will need to be 
addressed in further studies. Firstly, as is 
noted above, the authors attempt to make 
the distinction between a post-infl amma-
tory scar and an area of what they would 
call  ‘ true ’ FSGS on the basis of the presence 
of hyalinosis lesions and / or epithelial hyper-
plasia. However, they do not provide evi-
dence that these are valid criteria for making 
the distinction. Secondly, as they admit, 
they do not show that there is agreement 
between diff erent pathologists in classifying 
the diff erent types of FSGS. Th irdly, since 
their criteria for the cellular form of FSGS 
require the presence of endocapillary hyper-
cellularity, it is clear that these biopsies 
would have been scored in the Oxford clas-
sifi cation as E1, and so further analysis will 
be necessary to ask how this should be 
incorporated into the Oxford schema. 
Finally, as they themselves point out, 80 % of 
their biopsies showed some form of FSGS, 
which is a higher proportion than previ-
ously reported. Th us, their results will need 
to be validated in other groups of patients. 
 In conclusion, these papers 3,4 should 
make us reconsider the signifi cance of 
segmental sclerosis in IgA nephropathy. It 
is likely that there are at least three ways 
that segmental sclerosis may occur in 
glomeruli in IgA nephropathy ( Figure 1 ): 
firstly, by post-inflammatory scarring; 
secondly, due to compensatory hemody-
namic changes following loss of nephrons; 
and thirdly, as these papers emphasize, by 
primary podocyte damage, perhaps sec-
ondary to mediators released from 
mesangial cells. If a signifi cant percentage 
of segmental sclerotic lesions represent 
the consequence of primary podocyte 
damage, it may lead us to consider new 
pathogenic mechanisms and may also 
have therapeutic consequences. In addi-
tion, we may need to refi ne the way in 
which we assess segmental sclerosis in 
determining the prognostic implications 
of histology. It is reassuring that the stud-
ies reported here support the conclusions 
of the Oxford classifi cation, but they raise 
the possibility that the utility of the 
classifi cation could be further enhanced 
by the distinguishing of diff erent types of 
segmental sclerosis. Th at possibility will 
require confirmation of the results in 
other larger cohorts. 
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 BACKGROUND 
 Th e clinical management of patients 
with circulating alloantibodies in  renal 
transplantation is almost exclusively 
 focused on antibodies against ABO 
blood group antigens and the  human 
leukocyte antigen (HLA) system. 
Th ere is solid and universally accepted 
evidence for an important role of anti-
HLA antibodies in both early / acute 
and late / chronic rejection of renal allo-
graft s. We now possess a number of 
diff erent cell-based assays (cytotoxic or 
fl ow cyto metric cross-match) and solid-
phase assays (enzyme-linked immuno-
sorbent assay, HLA-coated beads) that 
reliably detect poten tially alloreac-
tive antibodies ( Figure 1 ). Th e recently 
 Non-HLA antibodies in 
kidney allograft rejection: 
convincing concept in need 
of further evidence 
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 Mostly indirect evidence suggests an important pathogenic role for 
non-HLA anti-endothelial cell antibodies (AECAs) in both acute and 
chronic rejection. The lack of standardized screening assays for AECAs 
unfortunately hampers the systematic collection of data in multicenter 
trials. Diagnostic tests based on commercially available platforms could 
pave the way for testing larger patient cohorts, but they still suffer from 
some important limitations. 
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